Daniel Ek discusses his journey co-founding Spotify and his new healthcare venture, Neko, which aims to revolutionize preventive care through a vertically integrated, data-driven model. He critiques the US healthcare system's reactive nature and incentive misalignment, and shares insights on AI's potential in health diagnostics and the value of open-source models.
Summarized by Podsumo
Neko offers a $499 annual health checkup that includes 53 blood markers, skin imaging for 950+ moles, and uninterrupted clinician time, targeting early detection of chronic diseases.
Daniel Ek draws parallels between Spotify's data-driven personalization and Neko's use of multimodal longitudinal data to shift healthcare from reactive to preventive.
The US healthcare system spends 18% of GDP yet suffers from misaligned incentives, such as short employer tenure discouraging long-term preventive investments.
AI applications at Neko include flagging skin lesions and tracking changes over time, exemplifying how AI can augment human clinicians for better outcomes.
Ek advocates for open-source AI models, noting that compute power, not just model architecture, is a key differentiator for safety and capability.
"If you discover things early, they're totally preventable, and the cost of dealing with them is very small, and the suffering for the person is very small too."
"For me, it is like 'show me the outcome, I'll show you the incentive.' The entire healthcare system is predicated on fixing you acutely when there are massive symptoms."
"Every great technology has extreme positives and extreme negatives, and it's really up to us now to steer this towards the outcome that we want."